Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diso is a health and wellness biotechnology company that specializes in the development and commercialization of oral thin film (OTF) delivery systems. The company's technology focuses on improving the bioavailability and convenience of vitamins, minerals, and supplements by allowing them to dissolve instantly on the tongue, bypassing traditional digestive hurdles. Diso offers a range of products targeting sleep, energy, and general nutrition, positioning itself at the intersection of advanced drug delivery and consumer healthcare. Their platform is designed to provide a faster-acting and more efficient alternative to traditional pills and capsules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on mydiso.com.